
Revelation Biosciences, Inc. – NASDAQ:REVBW
Revelation Biosciences stock price today
Revelation Biosciences stock price monthly change
Revelation Biosciences stock price quarterly change
Revelation Biosciences stock price yearly change
Revelation Biosciences key metrics
Market Cap | 2.69M |
Enterprise value | N/A |
P/E | -0.01 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 0.31 |
PEG ratio | N/A |
EPS | -30.94 |
Revenue | N/A |
EBITDA | -9.42M |
Income | -8.96M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeRevelation Biosciences stock price history
Revelation Biosciences stock forecast
Revelation Biosciences financial statements
Jun 2023 | 0 | -1.44M | |
---|---|---|---|
Sep 2023 | 0 | -2.62M | |
Dec 2023 | 37.57K | -2.20M | -5862.84% |
Mar 2024 | 0 | -2.68M |
Jun 2023 | 16038838 | 4.62M | 28.83% |
---|---|---|---|
Sep 2023 | 14218520 | 5.39M | 37.98% |
Dec 2023 | 12212609 | 5.56M | 45.57% |
Mar 2024 | 14701610 | 5.22M | 35.56% |
Jun 2023 | -1.99M | 0 | 15 |
---|---|---|---|
Sep 2023 | -1.71M | 0 | 0 |
Dec 2023 | -2.00M | 0 | 0 |
Mar 2024 | -2.83M | -19.17K | 5.41M |
Revelation Biosciences alternative data
Jan 2024 | 6 |
---|---|
Feb 2024 | 6 |
Mar 2024 | 9 |
Apr 2024 | 9 |
May 2024 | 9 |
Jun 2024 | 9 |
Jul 2024 | 9 |
Revelation Biosciences other data
Period | Buy | Sel |
---|---|---|
Sep 2021 | 0 | 654546 |
Feb 2022 | 103000 | 0 |
-
What's the price of Revelation Biosciences stock today?
One share of Revelation Biosciences stock can currently be purchased for approximately $0.01.
-
When is Revelation Biosciences's next earnings date?
Unfortunately, Revelation Biosciences's (REVBW) next earnings date is currently unknown.
-
Does Revelation Biosciences pay dividends?
No, Revelation Biosciences does not pay dividends.
-
How much money does Revelation Biosciences make?
Revelation Biosciences has a market capitalization of 2.69M.
-
What is Revelation Biosciences's stock symbol?
Revelation Biosciences, Inc. is traded on the NASDAQ under the ticker symbol "REVBW".
-
What is Revelation Biosciences's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Revelation Biosciences?
Shares of Revelation Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Revelation Biosciences have?
As Jul 2024, Revelation Biosciences employs 9 workers.
-
What is Revelation Biosciences's official website?
The official website for Revelation Biosciences is revbiosciences.com.
-
Where are Revelation Biosciences's headquarters?
Revelation Biosciences is headquartered at 5 West 21st Street, New York, NY.
-
How can i contact Revelation Biosciences?
Revelation Biosciences's mailing address is 5 West 21st Street, New York, NY and company can be reached via phone at +91 76225800.
Revelation Biosciences company profile:

Revelation Biosciences, Inc.
revbiosciences.comNASDAQ
9
Biotechnology
Healthcare
Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company's lead therapeutic candidate is REVTx-99, an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses, such as SARS-CoV-2 comprising its variants, influenza A and B, parainfluenza, rhinovirus, and RSV, as well as is being developed for other indications comprising allergic rhinitis and chronic nasal congestion. It also develops REVTx-200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for immunity; and REVDx-501, a rapid home use diagnostic to detect respiratory viral infection. The company was founded in 2019 and is based in New York, New York.
New York, NY 10010
CIK: 0001810560
ISIN: US76135L1199
CUSIP: 76135L119